Literature DB >> 16711021

Partial horizontal laryngectomy and epiglottiplasty.

Hui Huangfu1, Binquan Wang, Weijia Kong, Shusheng Gong, Shuxin Wen.   

Abstract

In order to evaluate the availability of the lateral horizontal laryngectomy and anaplasty of epiglottis to treat some patients with specific supraglottic carcinomas and hypopharyngeal carcinomas, 17 cases of laryngeal and hypopharyngeal carcinomas were retrospectively analyzed, whose tumors were located at the lateral margin of epiglottis, aryepiglottic fold, medial wall of piriform fossa and were treated by the lateral horizontal laryngectomy and anaplasty of epiglottis. The results showed that all cases took food by mouth in postoperative 9-14 days and subjected to decannulation in postoperative 9-15 days. Three cases had postoperative hoarse voice. The free-disease survival rate of 3 years was 71.4% in 14 cases followed up after the first surgical therapy, and the overall free-disease survival rate of 3 years was 85.7% after the second surgical therapy. It was concluded that the manipulations of the lateral horizontal laryngectomy and epiglottiplasty were simple. It could alleviate the postoperative symptoms of aspiration and bucking remarkably and shorten their postoperative recovery time, yet does not lower the survival rate of patients if laryngocarcinoma or hypopharyngeal carcinoma cases were properly selected.

Entities:  

Mesh:

Year:  2006        PMID: 16711021     DOI: 10.1007/bf02828053

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

Review 1.  The use of intensity-modulated radiation therapy in the treatment of oropharyngeal carcinoma.

Authors:  Samir Narayan
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2005-08       Impact factor: 2.064

2.  Laser surgery in the larynx. Early clinical experience with continuous CO 2 laser.

Authors:  M S Strong; G J Jako
Journal:  Ann Otol Rhinol Laryngol       Date:  1972-12       Impact factor: 1.547

3.  Supraglottic laryngeal cancer: analysis of treatment results.

Authors:  Donald G Sessions; Jason Lenox; Gershon J Spector
Journal:  Laryngoscope       Date:  2005-08       Impact factor: 3.325

4.  Results of larynx preservation surgery for advanced laryngeal cancer through tracheal autotransplantation.

Authors:  P R Delaere; V Vander Poorten; C Vanclooster; A Goeleven; R Hermans
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-10

Review 5.  Management of carcinoma of the supraglottic larynx: evolution, current concepts, and future trends.

Authors:  E N Myers; A Alvi
Journal:  Laryngoscope       Date:  1996-05       Impact factor: 3.325

6.  Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma.

Authors:  M F Spafford; J Koeppe; Z Pan; P G Archer; A D Meyers; W A Franklin
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1996-06

7.  Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.

Authors:  Everett E Vokes; Kerstin Stenson; Fred R Rosen; Merrill S Kies; Alfred W Rademaker; Mary Ellyn Witt; Bruce E Brockstein; Marcy A List; Bing Bing Fung; Louis Portugal; Bharat B Mittal; Harold Pelzer; Ralph R Weichselbaum; Daniel J Haraf
Journal:  J Clin Oncol       Date:  2003-01-15       Impact factor: 44.544

8.  Partial laryngectomy with imbrication laryngoplasty for glottic carcinoma.

Authors:  Gady Har-El; Randy C Paniello; Elliot Abemayor; Dale H Rice; Christopher Rassekh
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.